Trimorphamid

CAS : 60029-23-4

Ref. 3D-KCA02923

Informations sur le produit

• Nom: Trimorphamid
• Synonymes: Brn 0982511, Ccris 3702, Fademorf, Fademorf EK 20, Fademorf ZK 20, Formamide, N-(2,2,2-trichloro-1-(4-morpholinyl)ethyl)-, Formamide, N-(2,2,2-trichloro-1-(morpholinyl)ethyl)-, Formamide, N-(2,2,2-trichloro-1-morpholinoethyl)-, N-(1-Formamido-2,2,2-trichloretyl)morfolin, N-(1-Formamido-2,2,2-trichloretyl)morfolin [Czech], N-(1-Formamido-2,2,2-trichloroethyl)morpholine, N-(2,2,2-Trichloro-1-morpholinoethyl)formamide, N-[2,2,2-Trichloro-1-(4-morpholinyl)ethyl]formamide, N-[2,2,2-trichloro-1-(morpholin-4-yl)ethyl]formamide, Trimorfamid, Trimorfamide, VUAgT 866, VUAgT 866/72

Description

Trimorphamid is an analog that has been shown to be a potent inhibitor of tumor protein kinase. This compound has been found in human urine and is believed to have anticancer properties. Trimorphamid inhibits the activity of various protein kinases, which play a critical role in cancer cell proliferation and survival. It induces apoptosis in Chinese hamster ovary cells and inhibits the growth of polysaccharide-induced tumors in mice. Trimorphamid also shows promising results as an adenosine kinase inhibitor, which could potentially be useful for treating various diseases such as asthma and inflammation. Overall, Trimorphamid is a promising compound with potential therapeutic applications in cancer treatment and other diseases related to protein kinase activity.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 261.5 g/mol
• Formule: C₇H₁₁Cl₃N₂O₂
• Degré de pureté: Min. 95%